Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2.
Level 5 - mechanism / opinion, no new human data
Preclinical animal model (transgenic mice) and mechanistic tissue correlation
PubMed 24345162 · doi:10.1111/jnc.12640
What was done
Researchers evaluated plasma and brain fatty acid profiles along with blood-brain barrier uptake of [14C]-DHA using in situ cerebral perfusion in 4- and 13-month-old male and female APOE-targeted replacement mice (APOE2, APOE3, and APOE4) fed a DHA-depleted diet. They also examined the relationship between cortical DHA and apoE concentrations in mice and in human Alzheimer's disease (AD) patients.
What was found
- Cortical DHA was 9% lower in APOE4 compared to APOE2 mice. - Plasma DHA was 34% higher in APOE4 compared to APOE2 mice. - Brain uptake of [14C]-DHA was 24% lower in APOE4 versus APOE2 mice. - Cortical DHA and apoE concentrations were correlated in mice (r² = 0.21) and in human AD patients (r² = 0.32).
Why it matters
This study outlines a mechanistic explanation—reduced blood-brain barrier transport and lower cerebral accumulation of DHA—for why human APOE4 carriers often fail to achieve cognitive benefit from DHA supplementation.
Limits
The primary transport measurements were conducted in transgenic mouse models on a DHA-depleted diet rather than in living humans. Sample sizes, statistical variance, and patient details for the human brain tissue correlation are omitted from the abstract, and functional cognitive outcomes were not tested.
Cited by
- supports Research by Norman Salem showed a defect in DHA transport across the blood-brain barrier in animals carrying human APOE4 compared to APOE2 and APOE3.